The effects of acute sildenafil administration on inflammatory markers in patients with vasculogenic erectile dysfunction [Η οξεία επίδραση της σιλδεναφίλης σε φλεγμονώδεις δείκτες σε ασθενείς με αγγειακής αιτιολογίας στυτική δυσλειτουργία].

Trial Profile

The effects of acute sildenafil administration on inflammatory markers in patients with vasculogenic erectile dysfunction [Η οξεία επίδραση της σιλδεναφίλης σε φλεγμονώδεις δείκτες σε ασθενείς με αγγειακής αιτιολογίας στυτική δυσλειτουργία].

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2014

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Mar 2014 Status changed from recruiting to completed, as per European Clinical Trials Database record.
    • 30 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top